240 related articles for article (PubMed ID: 8494718)
1. Antisense technology for cancer therapy: does it make sense?
Carter G; Lemoine NR
Br J Cancer; 1993 May; 67(5):869-76. PubMed ID: 8494718
[No Abstract] [Full Text] [Related]
2. Antisense treatment of viral infection.
Whitton JL
Adv Virus Res; 1994; 44():267-303. PubMed ID: 7817875
[TBL] [Abstract][Full Text] [Related]
3. Antisense tumor therapy (a dream under construction).
Kopper L; Kovalszky I
In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725
[TBL] [Abstract][Full Text] [Related]
4. Making sense of antisense.
Murakami A
Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507
[No Abstract] [Full Text] [Related]
5. [The application of antisense technology in ophthalmology].
Guo Y; Ge J
Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
[TBL] [Abstract][Full Text] [Related]
6. Antisense DNA and RNA strategies: new approaches to therapy.
Gibson I
J R Coll Physicians Lond; 1994; 28(6):507-11. PubMed ID: 7884705
[TBL] [Abstract][Full Text] [Related]
7. Molecular therapeutic strategies in hepatitis B virus infection.
Offensperger WB; Blum HE; Gerok W
Clin Investig; 1994 Oct; 72(10):737-41. PubMed ID: 7865975
[TBL] [Abstract][Full Text] [Related]
8. Antisense and sensibility.
Dove A
Nat Biotechnol; 2002 Feb; 20(2):121-4. PubMed ID: 11821852
[No Abstract] [Full Text] [Related]
9. Antisense strategies in degenerative joint diseases: sense or nonsense?
Huber LC; Distler O; Gay RE; Gay S
Adv Drug Deliv Rev; 2006 May; 58(2):285-99. PubMed ID: 16574269
[TBL] [Abstract][Full Text] [Related]
10. Antisense DNA and RNA agents against picornaviruses.
Lim T; Yuan J; Zhang HM; Sall A; Liu Z; Su Y; Yang D
Front Biosci; 2008 May; 13():4707-25. PubMed ID: 18508540
[TBL] [Abstract][Full Text] [Related]
11. Utility of antioncogene ribozymes and antisense oligonucleotides in reversing drug resistance.
Funato T
Methods Mol Med; 2005; 106():215-33. PubMed ID: 15375319
[No Abstract] [Full Text] [Related]
12. Gene therapy for HIV.
Lever AM
Sex Transm Infect; 2001 Apr; 77(2):93-6. PubMed ID: 11287684
[No Abstract] [Full Text] [Related]
13. RNA as a target for developing antivirals.
McKnight KL; Heinz BA
Antivir Chem Chemother; 2003 Mar; 14(2):61-73. PubMed ID: 12856917
[TBL] [Abstract][Full Text] [Related]
14. DNA combination therapy to stop tumor growth.
Wickstrom E; Smith JB
Cancer J Sci Am; 1998 May; 4 Suppl 1():S43-7. PubMed ID: 9619270
[No Abstract] [Full Text] [Related]
15. Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.
Rossi JJ; Sarver N
Adv Exp Med Biol; 1992; 312():95-109. PubMed ID: 1514448
[No Abstract] [Full Text] [Related]
16. Therapeutic antisense and ribozymes.
Rossi JJ
Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
[TBL] [Abstract][Full Text] [Related]
17. Antisense approaches to cancer gene therapy.
Mercola D; Cohen JS
Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
[TBL] [Abstract][Full Text] [Related]
18. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.
Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO
Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650
[TBL] [Abstract][Full Text] [Related]
19. Therapies that make sense.
Akhtar S; Ivinson AJ
Nat Genet; 1993 Jul; 4(3):215-7. PubMed ID: 8358426
[No Abstract] [Full Text] [Related]
20. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
Alvarez-Salas LM; BenÃtez-Hess ML; DiPaolo JA
Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
